Chapter 6, cont
(Page 3)
Is the patient adequately oxygenated?
FICK EQUATION
The Fick equation expresses the important relationship of tissue
oxygen uptake (VO2) to cardiac output (QT) and the
arterialvenous oxygen content difference (CaO2
CvO2):
(Eqn 6-3)
where CaO2 is the arterial oxygen content, and CvO2 is the mixed venous oxygen content.
This equation can be conceptually derived by thinking about oxygen delivery as follows: the amount of oxygen delivered to the tissues per minute equals the cardiac output (QT) times the arterial oxygen content (CaO2) (see Fig. 61). The total amount of venous oxygen delivered to the right side of the heart is the cardiac output times the venous oxygen content, or QT x CvO2. The total venous oxygen delivery must also equal the arterial oxygen delivery minus the amount of oxygen extracted by the tissues (VO2).
Hence,
(Eqn 6-4)
Rearranging,
(Eqn 6-5)
(Eqn 6-3)
Average resting values for a normal subject are QT, 5000 ml/min; CaO2, 20 ml/100 ml blood; CvO2, 15 ml/100 ml blood; and VO2, 250 ml/min.
Substituting these values into Equations 4 and 3:
750 ml O2/min = 1000 ml O2/min - (4)
250 ml O2/min
and,
250 ml O2/min =
(VO2)
5000 ml blood/min x (3)
(Cardiac output)
5 ml O2/100 ml blood
(CaO2 CvO2)
| Clinical Problem 7 |
| What is the oxygen uptake in the following situation: hemoglobin content, 15 Gm%; pH, 7.5; PaCO2, 30 mm Hg; PaO2, 80 mm Hg; SvO2, 75%; and cardiac output, 5.2 L/min? Assume the patient has a normal body temperature. |
| Clinical Problem 8 |
| A 49yearold man is admitted to the hospital with a massive gastrointestinal hemorrhage. Because of his persistent bleeding and his low hemoglobin level of 6 gm% despite receiving a transfusion, he is taken to the operating room for surgery. Before the operation, a Swan-Ganz catheter is placed, and cardiac output is measured at 7.5 L/min. At the same time his arterial PO2 is 125 mm Hg, and SaO2 is 97%. Assuming his oxygen requirement of 250 ml/min is being met, what is his (CaO2 - CvO2)? |
MIXED VENOUS OXYGEN SATURATION
At the present time our ability to assess oxygenation is limited to the whole patient and does not extend to assessment of the individual organs. Specific organ hypoxia is usually recognized only after damage has occurred. This situation is unfortunate since some clinical conditions (e.g., septic shock) may cause selective organ hypoxia even though the global oxygen supply is adequate.
For patients with a normal mental status and a normal or nearnormal cardiac output (determined by the history, physical examination, and chest xray), knowledge of their arterial oxygen content (CaO2) is usually sufficient to assess the adequacy of oxygen delivery. This is often not true for patients with impaired cardiac output or hemodynamic instability (e.g., shock); in this group the single best measurement to assess oxygenation is usually the mixed venous oxygen saturation (SvO2). Why is this so?
Equation 3 helps to explain the importance of SvO2 in assessing oxygen adequacy. Arterial oxygen delivery is the product of cardiac output (QT) and arterial oxygen content (CaO2); reduction in either QT or CaO2 threatens the adequacy of oxygen delivery. In either case (reduced QT or reduced CaO2), lactic acidosis and death will ensue if tissue oxygen uptake (VO2) is not maintained by the product of QT times the (CaO2 CvO2).
From Equation 3, the compensatory mechanisms for any decrease in oxygen delivery can be deduced; these mechanisms are outlined in Table 64 .
When cardiac output is decreased or when cardiac output cannot compensate for a decrease in CaO2, the mixed venous oxygen content (and thus SvO2 and PvO2) will fall. Normally both the cardiac output and the (CaO2 CvO2) can increase up to threefold as compensation: up to 15 L/min for QT and 15 ml O2/100 ml for (CaO2 CvO2). Increasing (CaO2CvO2) is almost always at the expense of lowering CvO2*; thus SvO2 is a barometer of the adequacy of oxygen delivery (QT x CaO2) for the body's oxygen needs.
When the SvO2 falls to 40% or less (roughly corresponding to a PvO2 of 27 mm Hg at pH 7.36), the limits of compensation are such that any further fall will likely result in lactic acidosis. This condition should be considered preterminal unless reversal is fairly rapid.
The problems in using SvO2 to assess global oxygenation
are both technical and theoretical. Technical problems in obtaining
a pulmonary artery sample are discussed in Chapter 8. Assuming
that a proper sample is obtained and that the measurement is accurate,
the following statement appears valid in patients at rest: a
low SvO2 indicates inadequate oxygen delivery for the
body's needs; the lower the SvO2, the more severe is
the derangement.
| Table 6-4. Compensatory mechanisms for decrease in oxygen delivery | ||
| Problem | Compensatory mechanism | Effect on CvO2, SvO2, and PvO2* |
| Decreased QT | Increase in (CaO2CvO2) | All reduced |
| Decreased CaO2(low SaO2 or anemia) | Increase in QT | All normal |
| Maintenance of (CaO2CvO2) | All reduced | |
| *PvO2, partial pressure of oxygen in mixed venous blood. | ||
Conversely, a normal SvO2 does not assure that oxygenation
is adequate; this is so for several reasons.
1. Regional hypoperfusion may be masked by an adequate blood flow to the rest of the body; thus one organ could be oxygen deficient, yet its oxygenpoor venous blood flow may not be enough to cause significant reduction in the mixed venous oxygen content.
2. Lefttoright systemic shunts may have the same effect as regional hypoperfusion. These shunts have been described in both septic and hemodynamic shock. If oxygenated blood is shunted from the arteries to the veins (thus bypassing capillaries), a normal (or even elevated) SvO2 may result. This measurement could be falsely reassuring since selective tissues or organs may be critically hypoxic and on the verge of irreversible damage.
3. In some conditions, such as cyanide poisoning, oxygen delivery
is adequate but the mitochondria are poisoned; thus oxygen transfer
between systemic capillaries and the tissue cells does not take
place. Again, SvO2 may be normal or above normal.
In summary, SvO2 is the best single measurement to use in assessing the adequacy of oxygenation in critically ill patients. If SvO2 is reduced, the patient's ability to efficiently oxygenate the tissues is either impaired or severely strained. If SVO2 is normal, oxygenation is probably adequate as long as there is no problem with regional hypoperfusion, lefttoright shunts, or mitochondrial oxygen uptake.
The PvO2 measurement is an alternative to SvO2
in assessing oxygenation. Both are obtained from mixed venous
blood. Of the two, the SvO2 should be more reliable
since it is solely a function of arterial oxygen delivery and
oxygen uptake. In contrast, PvO2 depends on the SvO2
and on the position of the oxygen dissociation curve. Venous
blood is more acidotic than arterial blood; hence the venous oxygen
dissociation curve is shifted to the right of the arterial curve.
For a given SvO2, the more the rightward shift of the
curve, the higher the PvO2. Other factors besides pH
will also influence the curve, such as the concentration of 2,3diphosphoglycerate;
thus the exact relationship of SvO2 to PvO2
cannot be predicted in sick patients. If the PvO2 is
used to assess oxygenation, it must be measured and not simply
estimated from the SvO2. An SvO2 measurement
of 75% could represent a range of PvO2 values depending
on the position of the oxygen dissociation curve.
| Clinical Problem 9 |
| What are the SvO2 and PvO2 in each of the following situations? In each, the lungs and acidbase state are normal in a 30yearold patient; the barometric pressure is 760 mm Hg, and the alveolararterial partial pressure of oxygen difference is normal. a. Cardiac output, 5 L/min; FIO2, 0.21; hemoglobin, 15 gm%; oxygen uptake 250 ml/min b. Same as in a, except cardiac output is 2.5 L/min c. Same as in a, except FIO2 is 1.00 d. Same as in a, except hemoglobin content is 8 gm% |
| Clinical Problem 10 |
| A 69yearold woman with progressive congestive heart failure is being treated in the intensive care unit. Because of a decreasing urinary output, a SwanGanz catheter is inserted in her pulmonary artery. The patient's cardiac output and her mixed venous oxygen measurements are obtained along with her arterial blood gas measurements: cardiac output, 2.9 L/min; PaO2, 74 mm Hg; SaO2, 92%; CaO2, 14.5 vol%; SvO2, 54%; and PvO2, 26 mm Hg.
The patient is treated with intravenous dobutamine, a drug that stimulates the myocardium to augment cardiac output. Three hours later the following measurements are obtained: cardiac output, 3.8 L/min; PaO2, 76 mm Hg; SaO2, 93%; CaO2, 14.5 vol%; SvO2, 65%; PvO2, and 34 mm Hg. Do her mixed venous oxygen measurements (SvO2, PvO2) reflect the arterial oxygen measurements (PaO2, SaO2)? How is the change in mixed venous oxygen measurements explained? |

Fig. 65. Changes in SvO2 when monitored
continuously. A, Effect on SvO2 of a, suctioning
the patient's tracheal tube, b, bathing and weighing the patient,
and c, turning the patient and changing his bed linen. Note the
prolonged duration of the SvO2 of less than 60%. B,
Gradual decline in SvO2 over the first 20 minutes heralded
onset of cardiac arrest (arrow) for which resuscitation
was successful. (From Baele, P.L., McMichan, J.C., Marsh, H.M.,
et al.: Anesth. Analg. 61:513517, 1982.)
Obviously, a mixed venous oxygen measurement is done only on very sick patients in whom there is reason to suspect inadequate oxygen delivery. There may also be technical problems in obtaining a proper sampleit is not a simple test to be performed repeatedly (see Chapter 8). A fiberoptic sensor in some models of the SwanGanz catheter allows for continuous measurement of SvO2. This modification greatly improves the monitoring of mixed venous oxygenation and also demonstrates how clinical changes can affect mixed venous oxygenation (Fig. 65). Fig. 65, A, demonstrates that routine nursing procedures (tracheal suctioning and weighing) can lower SvO2. Fig. 65, B, shows the SvO2 tracing from a patient who developed cardiac arrest. Before the arrest, the SvO2 declined precipitously and, in fact, heralded the problem.*
Mixed venous oxygen measurement represents a sophisticated attempt
to answer the sometimes difficult question about the adequacy
of overall oxygenation. However, for the vast majority of patients,
measurement of arterial oxygen content will be sufficient to assess
oxygenation.
SUMMARY
The second clinical question concerning oxygenation asks if oxygenation is adequate for the patient. This is sometimes a difficult question to answer. Unlike the first question posed in Chapter 5 (Are the lungs transferring oxygen properly'?), the answer to this question must always include information from the patient's history and physical examination. The most important laboratory measurement to help answer this question is the arterial oxygen content (CaO2). CaO2 is the amount of oxygen in the blood measured in ml O2/100 ml blood and is determined by multiplying the hemoglobin oxygen saturation (SaO2) times the hemoglobin content (in gm/100 ml blood) times 1.34 ml °2/ gm hemoglobin (hemoglobin's oxygen binding capacity).
Carbon monoxide affects oxygenation in two ways. First, it prevents oxygen from binding to hemoglobin, thus reducing the SaO2; for every percent carboxyhemoglobin, SaO2 is reduced 1%. Second, when carbon monoxide binds to hemoglobin, it causes a leftward shift of the oxygen dissociation curve, thus causing hemoglobin to hold onto oxygen more tightly than when carboxyhemoglobin is not present.
In critical illnesses such as shock or sepsis, the CaO2 alone may be insufficient to determine the adequacy of oxygenation. In such situations, cardiac output, arterial oxygen transport, oxygen uptake, and mixed venous oxygen saturation may be measured. Unfortunately, such information can only be obtained with the aid of right heart catheterization, an invasive technique.
Mixed venous oxygen saturation (SvO2) can be measured
continuously by using a pulmonary artery catheter that is equipped
with a special fiberoptic sensor. Continuous SvO2 measurement
has proved useful in monitoring the adequacy of oxygenation in
critically ill patients. A low SvO2 indicates inadequate
oxygen delivery for the body's needs. If the SvO2 is
normal, overall oxygenation is probably adequate, provided that
there is not significant regional hypoperfusion, lefttoright
shunting, or interference with mitochondrial oxygen uptake.
REVIEW QUESTIONS
State whether each of the following is true or false.
1. Units for oxygen content are ml O2/gm hemoglobin.
2. When PaO2 is 100 mm Hg, SaO2 is 98%, and hemoglobin content is 15 gm%, 86% of the available oxygen is carried on hemoglobin.
3. Mixed venous PO2 increases one mm Hg with each mm Hg increase in PaO2.
4. In a critically ill patient at rest, reduced SvO2 indicates inadequate oxygen delivery to the tissues.
5. A P50 of 33 mm Hg indicates a reduced SaO2 for a given PaO2.
6. Arterial oxygen delivery is the product of cardiac output times arterial oxygen content.
7. Anemia can lower arterial PO2 in the face of venous admixture.
8. To maintain oxygen uptake in the presence of a falling cardiac output, there must be a concomitant increase in the arterialvenous oxygen content difference.
9. Carbon monoxide shifts the oxygen dissociation curve to the left.
10. Methemoglobin shifts the oxygen dissociation curve to the
right.
References
Baele, P.L., McMichan, J.C., Marsh, H.M., et al.: Continuous monitoring of mixed venous oxygen saturation in critically ill patients, Anesth. Analg. 61:513, 1982.
Comroe, J.H., Jr., and Botelho, S.: The unreliability of cyanosis in the recognition of arterial hypoxemia, Am. J. Med. Sci. 214:1, 1947.
Winter, P.M., and Miller, J.N.: Carbon monoxide poisoning, JAMA
236:1502, 1976.
Suggested readings
Filley, G., Beckwith, H., Reeves, J., et al.: Chronic obstructive pulmonary disease: oxygen transport in two clinical types, Am. J. Med. 44:26, 1968.
Kandel, G., and Aberman, A.: Mixed venous oxygen saturation: its role in the assessment of the critically ill patient, Arch. Intern. Med. 143:1400, 1983.
Kasnitz, P., Drurger, G.L., Yorra, F., et al.: Mixed venous oxygen tension and hyperlactatemia, JAMA 236:570, 1976.
Miller, M.J.: Tissue oxygenation in clinical medicine: an historical review, Anesth. Analg. 61:527, 1982.
Mithoefer, J., Holfand, F., and Keighley, J.: The effect of oxygen
administration on mixed venous oxygenation in chronic obstructive
pulmonary disease, Chest 66:122, 1974.
See also General References in Appendix G.
[Table of Contents][Previous Chapter][Chapter 6, Page 1][Chapter 6, Page 2][Next Chapter]